SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (OTCBB:PURE) announced today that it has raised approximately $8.44 million in a private placement of its securities. After fees and expenses, the net proceeds to the Company were approximately $7.72 million. Michael L. Krall, President and CEO of PURE Bioscience, stated, “We are extremely gratified by this vote of confidence by our investors. This capital raise represents another step on the road toward the listing of our stock on a national exchange. We have several sales and distribution agreements in process and look forward to 2008 being our breakout year.”
